[Federal Register Volume 89, Number 120 (Friday, June 21, 2024)]
[Notices]
[Page 52097]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13621]



[[Page 52097]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Biopharmaceutical Manufacturing Preparedness 
Consortium

    Notice is hereby given that, on April 12, 2024, pursuant to section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. 4301 et seq. (``the Act''), Biopharmaceutical Manufacturing 
Preparedness Consortium (``BIOMAP-CONSORTIUM'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing changes in its membership. The 
notifications were filed for the purpose of extending the Act's 
provisions limiting the recovery of antitrust plaintiffs to actual 
damages under specified circumstances.
    Specifically, A-line, Inc., Signal Hill, CA; API Innovation Center, 
St. Louis, MO; AVS Bio, Norwich, CT; Advanced Concept Innovations, 
Lakeland, FL; Afton Scientific, Charlottesville, VA; Alchem 
Laboratories Corp., Alachua, FL; AmerStem, Inc., Camarillo, CA; 
American Medicines Company, PBC, Davisville, WV; American Type Culture 
Collection, Manassas, VA; Amyris, Inc., Emeryville, CA; AntoXa Corp., 
Toronto, CANADA; Apertus Pharmaceuticals LLC, Ballwin, MO; Argonaut 
Manufacturing Services, Inc., Carlsbad, CA; Asha Therapeutics LLC, 
Tampa, FL; Attogene Corp., Austin, TX; BASF Corp., Florham Park, NJ; 
BCG Federal Corp., Washington, DC; BDO Public Sector LLC, McLean, VA; 
Batavia Biosciences, Inc., Woburn, MA; Benuvia Operations LLC, Round 
Rock, TX; Bionova Scientific LLC, Fremont, CA; Biosortia 
Pharmaceuticals, Inc., Dublin, OH; Black Mesa Technology, Inc., 
Bedford, MA; Blu Zone Bioscience & Supply Chain Solutions, LLC, 
Frederick, MD; Bracane Company, Inc., Plano, TX; CGCN, Washington, DC; 
CMC Pharmaceuticals, Inc., Solon, OH; Capra Biosciences, Inc., 
Manassas, VA; ChromaTan, Inc., Lower Gwynedd, PA; Concept to Market 
LLC, Monrovia, MD; Cornerstone Chemical Company, Metairie, LA; Corning, 
Inc., Corning, NY; CuriRx, Inc., Wilmington, MA; DEKA Research & 
Development Corp., Manchester, NH; DMC Biotechnologies, Inc., Boulder, 
CO; Dyadic International, Inc., Jupiter, FL; EriVan Bio, Alachua, FL; 
EverGlade Consulting LLC, Houston, TX; Evimero, Tuscaloosa, AL; 
FUJIFILM Diosynth Biotechnologies USA, Inc., Morrisville, NC; Fisher 
BioServices, Inc., Rockville, MD; Foamtec International LLC, Waco, TX; 
Fraunhofer USA, Plymouth, MI; HDT Bio Corp., Seattle, WA; HERMES, LLC, 
Wilmington, NC; Health Blockchain Convergence, Inc., Tysons Corner, VA; 
INTACT SOLUTIONS LLC, New Milford, CT; InflaRx GmbH, Jena, GERMANY; 
Interbiome Partners LLC, Rockville, MD; Jubilant HollisterStier CMO, 
Spokane, WA; Kemp Proteins, Frederick, MD; LaCire LLC, Alexandria, VA; 
Latham BioPharm Group, Elkridge, MD; MalarVx, Inc., Seattle, WA; 
Mallinckrodt Specialty Generics dba SpecGx LLC, Webster Groves, MO; 
Manus Bio, Inc., Waltham, MA; Medical Countermeasures Coalition, 
Washington, DC; Meissner Filtration Products, Inc., Camarillo, CA; 
Michael Best Strategies, Washington, DC; MilliporeSigma, Burlington, 
MA; Nature's Toolbox, Inc., Rio Rancho, NM; New Horizon Biotech, Inc., 
Nazareth, PA; NewAge Industries, Inc., Southampton, PA; Nipro 
PharmaPackaging Americas Corp., Millville, NJ; On Demand 
Pharmaceuticals, Inc., Rockville, MD; PPD Development, L.P., 
Wilmington, NC; Par Sterile Product LLC, Rochester, MI; PharmaJet, 
Golden, CO; Phlow Corp., Richmond, VA; Prestige Ameritech, Ltd., North 
Richland Hills, TX; ProQuality Network LLC, Dorado, PUERTO RICO; 
Proteios Technology, Inc., Issaquah, WA; Quantum Four Labs LLC, 
Arcadia, CA; SANARIA, Inc., Rockville, MD; SCHOTT Pharma USA, Inc., 
Lebanon, PA; SK Pharmteco, Rancho Cordova, CA; STERIS Corp., Mentor, 
OH; Scorpius Biomanufacturing, Inc., San Antonio, TX; Sentio 
BioSciences LLC, Maryland Heights, MO; Sepragen Corp., Union City, CA; 
Shabas Solutions LLC, Fairfax, VA; Societal CDMO Inc., Gainesville, GA; 
Sotera Health Company, Broadview Heights, OH; Southwest Research 
Institute, San Antonio, TX; Strategic Marketing Innovations, 
Washington, DC; TEGA Therapeutics, Inc., San Diego, CA; TFF 
Pharmaceuticals, Inc., Fort Worth, TX; Tenagrity Solutions LLC, 
Fairfax, VA; Texas A&M Engineering Experiment Station, Bryan, TX; Texas 
Biomedical Research Institute, San Antonio, TX; Thaddeus Medical 
Systems, Inc., Rochester, MN; The United States Pharmacopeial 
Convention, Inc., Rockville, MD; Third Pole, Inc., Waltham, MA; Tonix 
Pharmaceuticals Holding Corp., Chatham, NJ; TriLink BioTechnologies 
LLC, San Diego, CA; US Specialty Formulations, Allentown, PA; 
University of Delaware, Newark, DE; Vaxess Technologies, Inc., 
Cambridge, MA; Wheeler Bio, Inc., Oklahoma City, OK; and Zalgen Labs 
LLC, Frederick, MD, have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and the BIOMAP-CONSORTIUM intends to 
file additional written notifications disclosing all changes in 
membership.
    On January 5, 2024, the BIOMAP-CONSORTIUM filed its original 
notification pursuant to section 6(a) of the Act. The Department of 
Justice published a notice in the Federal Register pursuant to section 
6(b) of the Act on April 16, 2024 (89 FR 26923).

Suzanne Morris,
Deputy Director Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2024-13621 Filed 6-20-24; 8:45 am]
BILLING CODE P